Literature DB >> 11134149

Cellular localization of uridine diphosphoglucuronosyltransferase 2B enzymes in the human prostate by in situ hybridization and immunohistochemistry.

O Barbier1, H Lapointe, M El Alfy, D W Hum, A Bélanger.   

Abstract

UDP-glucuronosyltransferase (UGT) enzymes catalyze the transfer of the glucuronide group from UDP-glucuronic acid to several exogenous or endogenous compounds, including steroid hormones. Although it is widely recognized that the liver is a major site of steroid glucuronidation, RT-PCR analysis has shown the expression of UGT2B transcripts in extrahepatic steroid target tissues such as the prostate. Measurement of androgen metabolites in human prostate revealed high levels of C(19) steroid glucuronides such as androsterone glucuronide and 3alpha-diol glucuronide, thus suggesting an important role of UGT2B enzymes in androgen metabolism. To investigate the cellular localization of UGT2B expression in the human prostate, the present in situ hybridization studies demonstrated the presence of UGT2B transcripts in epithelial cells lining the acinii. All basal cells were intensively labeled, whereas the luminal secretory cells were moderately labeled. To confirm these results, an immunohistological analysis was performed using a specific anti-UGT2B antibody. The presence of UGT2B proteins was observed in both basal and luminal cells of prostate epithelium, in fibrocytes of stroma and blood vessels, and in endothelial cells of blood vessels. Using a specific anti-UGT2B17 antibody, the expression of this androsterone-conjugating UGT enzyme was found exclusively in basal cells of the epithelium. These results demonstrate the expression of androgen-conjugating UGT2B enzymes in human prostatic epithelium. Moreover, they show for the first time a cell type-specific expression of an UGT2B isoform.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11134149     DOI: 10.1210/jcem.85.12.7019

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

1.  Testicular vs adrenal sources of hydroxy-androgens in prostate cancer.

Authors:  Tianzhu Zang; Mary-Ellen Taplin; Daniel Tamae; Wanling Xie; Clementina Mesaros; Zhenwei Zhang; Glenn Bubley; Bruce Montgomery; Steven P Balk; Elahe A Mostaghel; Ian A Blair; Trevor M Penning
Journal:  Endocr Relat Cancer       Date:  2017-06-29       Impact factor: 5.678

2.  Cloning of UGT1A9 cDNA from liver tissues and its expression in CHL cells.

Authors:  X Li; Y N Yu; G J Zhu; Y L Qian
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

3.  Expression of UGT2B7, a UDP-glucuronosyltransferase implicated in the metabolism of 4-hydroxyestrone and all-trans retinoic acid, in normal human breast parenchyma and in invasive and in situ breast cancers.

Authors:  Shelley A Gestl; Mitchell D Green; Debra A Shearer; Elizabeth Frauenhoffer; Thomas R Tephly; Judith Weisz
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

4.  Tissue distribution of human AKR1C3 and rat homolog in the adult genitourinary system.

Authors:  Joseph Azzarello; Kar-Ming Fung; Hsueh-Kung Lin
Journal:  J Histochem Cytochem       Date:  2008-06-23       Impact factor: 2.479

Review 5.  Farnesoid X receptor alpha: a molecular link between bile acids and steroid signaling?

Authors:  Marine Baptissart; Aurelie Vega; Emmanuelle Martinot; Silvère Baron; Jean-Marc A Lobaccaro; David H Volle
Journal:  Cell Mol Life Sci       Date:  2013-06-20       Impact factor: 9.261

Review 6.  UGT2B17 Polymorphism and Risk of Prostate Cancer: A Meta-Analysis.

Authors:  Marce-Amara Kpoghomou; Joella Eldie Soatiana; Fatch W Kalembo; Ghose Bishwajit; Wei Sheng
Journal:  ISRN Oncol       Date:  2013-09-09

7.  Uridine diphosphate-glucuronosyltransferase 2B15 D85Y gene polymorphism is associated with lower prostate cancer risk: a systematic review and meta-analysis.

Authors:  Xiao Zhong; Jiayu Feng; Ya Xiao; Pingxian Wang; Qiming Fan; Ronghua Wu; Wengang Hu; Chibing Huang
Journal:  Oncotarget       Date:  2017-04-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.